SI-BONE, Inc. - Common Stock (OQ:SIBN)

Apr 15, 2024 04:09 pm ET
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May 6,...
Mar 04, 2024 04:09 pm ET
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare...
Feb 26, 2024 04:09 pm ET
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023...
Feb 05, 2024 04:09 pm ET
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after...
Jan 30, 2024 08:30 am ET
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite® Implant System (Granite)...
Jan 08, 2024 08:30 am ET
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited revenue for fourth quarter and full year 2023. Fourth Quarter 2023...
Nov 14, 2023 04:09 pm ET
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New...
Nov 06, 2023 04:09 pm ET
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2023. Recent Financial Highlights Record...
Nov 01, 2023 04:09 pm ET
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Jefferies London Healthcare Conference in...
Oct 16, 2023 04:09 pm ET
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2023 after market close on Monday, November...
Sep 05, 2023 04:09 pm ET
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods
SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that certain CD Horizon® Solera® 5.5mm and 6.0mm posterior spinal fixation rods manufactured by Medtronic Sofamor...
Aug 29, 2023 04:09 pm ET
SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Morgan Stanley 21st Annual Global Healthcare...
Aug 07, 2023 04:09 pm ET
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2023. Recent Highlights Record worldwide revenue of...
Jul 19, 2023 04:09 pm ET
SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Canaccord Genuity 43rd Annual Growth...
Jul 17, 2023 04:09 pm ET
SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2023 after market close on Monday, August...
May 24, 2023 04:09 pm ET
SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Jefferies Healthcare Conference in New...
May 04, 2023 10:29 pm ET
SI-BONE Announces Pricing of Public Offering of Common Stock
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the pricing of its underwritten public offering of 3,775,000 shares of its common stock at a price to...
May 04, 2023 04:09 pm ET
SI-BONE Announces Launch of Public Offering of Common Stock
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that it has commenced an underwritten public offering of 3,775,000 shares of its common stock. Of the...
May 01, 2023 04:09 pm ET
SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2023. Recent Highlights Record worldwide revenue of...
Apr 24, 2023 04:09 pm ET
SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Bank of America Merrill Lynch Global...
Apr 10, 2023 04:09 pm ET
SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2023 after market close on Monday, May 1,...
Feb 27, 2023 04:09 pm ET
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent...
Feb 06, 2023 04:09 pm ET
SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter of 2022 after market close on Monday, February...
Jan 09, 2023 09:00 am ET
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited revenue for fourth quarter and full year 2022. Fourth Quarter 2022...
Jan 03, 2023 04:09 pm ET
SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 25th Annual Needham Growth Conference....
Dec 27, 2022 08:30 am ET
SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant System
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced an additional FDA clearance for iFuse Bedrock Granite®. New cleared indications...
Nov 07, 2022 04:09 pm ET
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2022. Recent Highlights Record worldwide...
Oct 17, 2022 04:04 pm ET
SI-BONE To Report Third Quarter 2022 Financial Results on November 7, 2022
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2022 after market close on Monday, November...
Aug 23, 2022 08:02 am ET
SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare...
Aug 08, 2022 04:02 pm ET
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2022. Recent Highlights Record worldwide revenue of...
Jul 18, 2022 08:00 am ET
SI-BONE To Present at The Canaccord Genuity 42nd Annual Growth Conference 2022
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that Laura Francis, CEO, and Anshul Maheshwari, CFO will be presenting at the upcoming Canaccord...
Jul 18, 2022 08:00 am ET
SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2022 after market close on Monday, August...
Jun 13, 2022 08:00 am ET
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
SI-BONE, Inc. (SIBN), (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced an FDA clearance for iFuse-TORQ® for pelvic fracture fixation, including...
May 31, 2022 08:00 am ET
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite Implant System (Granite)....
May 09, 2022 04:02 pm ET
SI-BONE, Inc. Reports First Quarter 2022 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Worldwide revenue of $22.4...
Apr 19, 2022 08:00 am ET
SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment
SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed a New...
Apr 18, 2022 04:03 pm ET
SI-BONE To Present at BofA Securities 2022 Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Conference in...
Apr 18, 2022 08:00 am ET
SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2022 after market close on Monday, May 9,...
Feb 28, 2022 04:02 pm ET
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights...
Feb 01, 2022 08:00 am ET
SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year 2021 after market close on...
Jan 10, 2022 07:00 am ET
SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited revenue for fourth quarter and full year...
Dec 27, 2021 04:03 pm ET
SI-BONE to participate in 24th Annual Needham Virtual Growth Conference
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced management is scheduled to participate in the following investor conference:...
Dec 13, 2021 04:02 pm ET
SI-BONE, Inc. Announces Updated Exclusive Blue Cross Blue Shield Association Evidence Street Opinion, and New Coverage Policies from Arkansas Blue Cross Blue Shield and Walmart Plans from BlueAdvantag
SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that Blue Cross Blue Shield Association (BCBSA) Evidence Street’s annual...
Nov 08, 2021 04:03 pm ET
SI-BONE, Inc. Reports Third Quarter 2021 Financial Results and Updates 2021 Financial Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2021. Recent Highlights Record worldwide...
Oct 18, 2021 04:03 pm ET
SI-BONE To Report Third Quarter 2021 Financial Results on November 8, 2021
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2021 after market close on Monday, November...
Oct 11, 2021 08:00 am ET
SI-BONE, Inc. Announces UnitedHealthcare Adopts Exclusive iFuse Only Coverage for Minimally Invasive SI Joint Fusion
SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that UnitedHealthcare has changed its minimally invasive SI joint fusion policy...
Aug 23, 2021 04:03 pm ET
SI-BONE to Participate in Upcoming Conferences
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that it will be participating in the following upcoming investor conferences: 19th Annual Morgan...
Aug 02, 2021 04:03 pm ET
SI-BONE, Inc. Reports Second Quarter 2021 Financial Results and Announces Exclusive Coverage from Anthem
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2021. Recent Highlights Record worldwide...
Aug 02, 2021 04:02 pm ET
SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangular iFuse Implant System® for Its More Than 40 Million Members
SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that Anthem, Inc. will cover minimally invasive SI joint fusion exclusively when...
Jul 29, 2021 07:00 am ET
SI-BONE to Present at the Canaccord Genuity 41st Annual Growth Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Canaccord Genuity 41st Annual Growth...
Jul 20, 2021 04:03 pm ET
SI-BONE To Report Second Quarter 2021 Financial Results on August 2, 2021
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2021 after market close on Monday, August...
Jul 14, 2021 07:00 am ET
SI-BONE, Inc. Announces Centene Establishes Positive Coverage for MIS SI Joint Fusion including the Triangular iFuse Implant System
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that Centene Corporation has established a positive coverage policy for...
Jul 07, 2021 04:03 pm ET
SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy announced the publication of 2-year results from SALLY (Study of bone growth in the Sacroiliac...
Jul 02, 2021 04:02 pm ET
SI-BONE, Inc. Announces the Introduction of the SI-BONE SImulator™ Powered by Medability for iFuse Surgeon Training and Education
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the worldwide launch of the SI-BONE SImulator™. The SI-BONE SImulator module is...
Jun 15, 2021 04:03 pm ET
French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.’s iFuse-3D Implant System™
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy announced that the French Health Ministry has granted national reimbursement for the iFuse-3D...
Jun 08, 2021 04:03 pm ET
SI-BONE to Present at the 2021 JMP Securities Life Sciences Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2021 JMP Securities Life Sciences Conference....
May 03, 2021 04:03 pm ET
SI-BONE, Inc. Reports First Quarter 2021 Financial Results and Reiterates 2021 Financial Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2021. Recent Highlights Worldwide revenue of $20.4...
Apr 22, 2021 04:02 pm ET
SI-BONE to Present at the 7th Annual Truist 2021 Life Sciences Summit and the 2021 Bank of America Health Care Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcoming 7th Annual Truist Securities 2021 Life...
Apr 19, 2021 07:00 pm ET
SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of Helen Loh and Laura Francis to the Board of Directors
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the appointment of Anshul Maheshwari as the company’s Chief Financial Officer...
Apr 15, 2021 04:02 pm ET
SI-BONE To Report First Quarter 2021 Financial Results on May 3, 2021
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2021 after market close on Monday, May 3,...
Mar 08, 2021 04:03 pm ET
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Issues 2021 Financial Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2020. Recent Highlights...
Feb 09, 2021 04:03 pm ET
SI-BONE To Report Fourth Quarter and Full Year 2020 Financial Results on March 8, 2021
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year 2020 after market close on...
Jan 07, 2021 07:00 am ET
SI-BONE Announces Senior Leadership Changes and Record Quarterly Revenue
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a Silicon Valley-based medical device company focused on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy, today announced its intention to...
Jan 04, 2021 07:00 am ET
SI-BONE, Inc. Announces that Updated ISASS Policy and Guidelines on MIS SI Joint Fusion Support Only Lateral Transiliac MIS Procedures
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that the International Society for the Advancement of Spine Surgery (ISASS)...
Dec 21, 2020 07:00 am ET
SI-BONE, Inc. Announces that Priority Health Became the 36th Payor with Exclusive iFuse Coverage Policy
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that effective November 25, 2020, Priority Health Michigan became the 36th U.S....
Dec 17, 2020 07:00 am ET
SI-BONE to Present at the 23rd Annual Needham Growth Conference and the 39th Annual J.P. Morgan Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcoming 23rd Annual Needham Growth Conference and...
Dec 16, 2020 07:00 am ET
SI-BONE, Inc. Announces that Humana Establishes Exclusive Coverage for iFuse in MIS SI Joint Fusion Procedures
SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that Humana has revised its coverage policies to cover minimally invasive SI...
Nov 02, 2020 04:02 pm ET
SI-BONE, Inc. Reports Third Quarter 2020 Financial Results and 2020 Revenue Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2020. Recent Highlights...
Oct 19, 2020 04:05 pm ET
SI-BONE To Report Third Quarter 2020 Financial Results on November 2, 2020
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2020 after market close on Monday, November...
Oct 14, 2020 10:00 pm ET
SI-BONE Announces Pricing of Public Offering of Common Stock
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy, today announced the pricing of its underwritten...
Oct 14, 2020 04:01 pm ET
SI-BONE Announces Launch of Public Offering of Common Stock
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy, today announced that it has commenced an...
Oct 08, 2020 08:05 am ET
SI-BONE Reports Preliminary Unaudited Revenue for the Third Quarter 2020 and Provides Full Year 2020 Revenue Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced preliminary unaudited revenue for the three and nine months ended September 30, 2020. Preliminary and...
Oct 01, 2020 04:05 pm ET
SI-BONE, Inc. to Host Virtual KOL Surgeon Panel at NASS
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that Jeffrey Dunn, Chairman and CEO, will host a virtual surgeon panel from 10am...
Sep 02, 2020 04:05 pm ET
SI-BONE to Present at the 2020 Cantor Global Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that the company will be participating in the upcoming 2020 Cantor Global Healthcare Conference.For...
Sep 01, 2020 07:30 am ET
SI-BONE to Present at the Morgan Stanley 18th Annual Global Healthcare Conference and the 2020 Cantor Global Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcoming Morgan Stanley 18th Annual Global...
Aug 25, 2020 04:05 pm ET
SI-BONE, Inc. Announces Exclusive, Positive iFuse Coverage decision by Medica
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that Medica published an exclusive, positive iFuse coverage policy effective...
Aug 03, 2020 04:05 pm ET
SI-BONE, Inc. Reports Second Quarter 2020 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2020. Recent Highlights Revenue of $14.0 million for...
Jul 30, 2020 04:09 pm ET
SI-BONE to Present at the 40th Annual Canaccord Genuity Growth Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcoming 40th Annual Canaccord Genuity Growth...
Jul 21, 2020 08:00 am ET
SI-BONE To Report Second Quarter 2020 Financial Results on August 3, 2020
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2020 after market close on Monday, August...
Jun 01, 2020 08:30 am ET
SI-BONE, Inc. Announces $40 Million Debt Re-Financing
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that it has re-financed its existing credit facility. Proceeds from the new $40...
May 29, 2020 09:18 am ET
SI-BONE, Inc. Announces Aetna Establishes Positive Coverage for MIS SI Joint Fusion using the Triangular iFuse Implant System
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that Aetna has established a positive coverage policy for minimally invasive SI...
May 27, 2020 04:05 pm ET
Notice of Change of Location of Annual Meeting of Stockholders of SI-BONE, Inc. to Be Held on June 16, 2020
SI-BONE, Inc. (Nasdaq: SIBN) announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of...
May 05, 2020 04:05 pm ET
SI-BONE to Present at the Bank of America Securities 2020 Health Care Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that the company will be participating in the upcoming Bank of America Securities 2020 Health Care...
May 04, 2020 04:05 pm ET
SI-BONE, Inc. Reports First Quarter 2020 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2020. Recent Highlights Revenue of $16.8 million...
Apr 22, 2020 08:00 am ET
SI-BONE To Report First Quarter 2020 Financial Results on May 4, 2020
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2020 after market close on Monday, May 4,...
Apr 02, 2020 09:00 am ET
SI-BONE, Inc. Provides Business Update in Response to COVID-19 Pandemic
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today provided an update on the actions it is taking to support patients, customers, and employees while maintaining...
Mar 09, 2020 04:05 pm ET
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2019. Recent Highlights...
Feb 19, 2020 04:05 pm ET
SI-BONE To Report Fourth Quarter 2019 Financial Results on March 9, 2020
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter of 2019 after market close on Monday, March 9,...
Jan 22, 2020 08:30 pm ET
SI-BONE Announces Pricing of Public Offering of Common Stock
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the pricing of its public offering of 4,300,000 shares of its common...
Jan 21, 2020 04:01 pm ET
SI-BONE Announces Launch of Public Offering of Common Stock
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that it has commenced an underwritten public offering of 4,300,000...
Jan 09, 2020 08:00 am ET
SI-BONE Reports Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2019 and Provides Full Year 2020 Revenue Guidance
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced preliminary unaudited revenue for the fourth quarter and full year 2019. Preliminary and unaudited...
Dec 13, 2019 09:18 am ET
SI-BONE, Inc. Announces CIGNA Establishes Positive Coverage for MIS SI Joint Fusion using the iFuse Implant System
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that CIGNA has established a positive coverage policy for minimally invasive SI...
Dec 04, 2019 04:05 pm ET
SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that Jeri Hilleman has joined its Board of Directors, effective immediately....
Dec 03, 2019 04:05 pm ET
SI-BONE to Participate at the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 31st Annual Piper Jaffray Healthcare Conference in...
Nov 11, 2019 04:05 pm ET
SI-BONE, Inc. Reports Third Quarter 2019 Financial Results and Updates Full-Year 2019 Revenue Guidance
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2019. Recent Highlights Revenue of $16.2 million...
Nov 04, 2019 08:00 am ET
SI-BONE Announces Medicare Physician Payment Increase of 27% for Minimally Invasive SI Joint Fusion
SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the Centers for Medicare and Medicaid Services (CMS) has updated the Medicare...
Oct 28, 2019 04:05 pm ET
SI-BONE To Report Third Quarter 2019 Financial Results on November 11, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2019 after market close on Monday, November...
Sep 26, 2019 07:30 am ET
SI-BONE, Inc. Announces Publication of Five-Year Prospective Study Results on 103 Patients Treated with Triangular Titanium iFuse Implant System
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced the publication of 5-year results from a long-term prospective study called...
Sep 03, 2019 08:00 am ET
SI-BONE, Inc. Announces Wellmark Blue Cross Blue Shield Establishes Positive Coverage for MIS SI Joint Fusion Using iFuse
SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that Wellmark Blue Cross Blue Shield (BCBS) has established positive coverage...
Aug 26, 2019 04:05 pm ET
SI-BONE to Present at the 17th Annual Morgan Stanley Global Healthcare Conference on September 10, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 17th Annual Morgan Stanley Global Healthcare...
Aug 06, 2019 04:05 pm ET
SI-BONE, Inc. Reports Second Quarter 2019 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2019. Recent Highlights Revenue of $16.3 million for...
Jul 24, 2019 04:05 pm ET
SI-BONE to Present at the Canaccord Growth Conference on August 8, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 2019 Canaccord Growth Conference.   SI-BONE’s...
Jul 23, 2019 04:05 pm ET
SI-BONE To Report Second Quarter 2019 Financial Results on August 6, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2019 after market close on Tuesday, August...
Jul 15, 2019 09:00 am ET
Survey of 1,000 Women Reveals 8 in 10 are Unaware that Sacroiliac Joint Issues are a Leading Cause of Chronic Lower Back Pain After Pregnancy
Results of a recent survey of 1,000 women (age 35 to 60) conducted by SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, found that 86% of respondents are unaware that sacroiliac (SI) joint dysfunction is a leading cause of chronic lower back pain for women over 35 who have been pregnant.
Jun 27, 2019 08:00 am ET
SI-BONE’s iFuse Implant System Surpasses 40,000 Procedures
SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that the iFuse Implant System® has been used in more than 40,000 sacroiliac joint...
Jun 17, 2019 08:00 am ET
SI-BONE Announces the Addition of Mark Foley and Heyward Donigan to the Board of Directors
SI-BONE, Inc., (Nasdaq: SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced that Mark J. Foley and Heyward R. Donigan, have joined the...
Jun 05, 2019 04:05 pm ET
SI-BONE to Present at the 2019 JMP Securities Life Sciences Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 2019 JMP Securities Life Sciences Conference....
May 08, 2019 04:05 pm ET
SI-BONE, Inc. Reports First Quarter 2019 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2019. Recent Highlights Revenues of $15.0 million...
Apr 29, 2019 04:05 pm ET
SI-BONE to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 2019 Bank of America Merrill Lynch Health Care...
Apr 24, 2019 04:05 pm ET
SI-BONE To Report First Quarter 2019 Financial Results on May 8, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2019 after market close on Wednesday, May 8,...
Apr 15, 2019 08:00 am ET
SI-BONE, Inc. Announces FDA Clearance of iFuse Bedrock™ Novel Spinopelvic Fixation Technology
SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley based medical device company dedicated to solving musculoskeletal disorders of the spinopelvic anatomy, today announced that it received an additional 510(k) clearance from the U.S. Food and Drug...
Mar 07, 2019 04:05 pm ET
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today reported financial results for the three months and full year ended December...
Mar 06, 2019 04:05 pm ET
SI-BONE, Inc. Announces Journal of Bone and Joint Surgery (JBJS) Publishes 2-Year Results from iMIA, a European Multicenter Randomized Controlled Trial (RCT) of SI Joint Fusion with  iFuse Implant Sys
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that pioneered minimally invasive surgery of the sacroiliac (SI) joint with the iFuse Implant System® (iFuse), announced publication of 2-year results from iMIA (iFuse Implant System Minimally...
Feb 28, 2019 04:05 pm ET
SI-BONE to Present at the Canaccord Genuity Musculoskeletal Conference
SI-BONE, Inc., (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the company will be participating in the upcoming Canaccord...
Feb 21, 2019 04:05 pm ET
SI-BONE To Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced it will report financial results for the fourth quarter and...
Feb 12, 2019 07:00 am ET
PrinterPrezz to Work With SI-BONE to Speed Innovation in Metal 3D Printed Orthopedic Medical Devices
PrinterPrezz, Inc., a trailblazer in combining metal 3D printing, nanotechnologies and surgical expertise to design and manufacture next generation medical devices, today announced that it has signed a customer agreement with SI-BONE, Inc. (NASDAQ: SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®. As part of the agreement, PrinterPrezz will provide SI-BONE with development and build services for potential future 3D-printed advanced medical devices and
Feb 07, 2019 08:00 am ET
Shockwave Appoints Laura Francis to Board of Directors
Shockwave Medical, a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today announced that Laura Francis has joined its Board of Directors and will serve as Chairperson...
Feb 04, 2019 09:00 am ET
SI-BONE, Inc. Announces Additional Exclusive Coverage Policies for iFuse
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that pioneered minimally invasive surgery of the sacroiliac (SI) joint with the iFuse Implant System® (iFuse) announced the addition of several exclusive coverage policies.  “We are pleased...
Jan 07, 2019 07:00 am ET
SI-BONE Reports Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today announced preliminary unaudited revenue for the fourth quarter and full...
Dec 20, 2018 04:05 pm ET
SI-BONE to Present at the 37th Annual J.P. Morgan Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the company will be participating in the upcoming 37th...
Dec 06, 2018 04:30 pm ET
SI-BONE, Inc. Announces Blue Cross Blue Shield of Arizona (BCBS AZ) Establishes Positive Coverage for MIS SI Joint Fusion Exclusively with the Triangular Titanium iFuse Implant System
SI-BONE, Inc., a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced that Blue Cross Blue Shield of Arizona (BCBS AZ), based on published clinical...
Nov 29, 2018 04:11 pm ET
SI-BONE, Inc. Reports Third Quarter 2018 Financial Results
SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today reported financial results for the quarter ended September 30, 2018. Recent...
Nov 07, 2018 12:45 pm ET
SI-BONE To Report Third Quarter Financial Results on November 29, 2018
SANTA CLARA, Calif., Nov. 7, 2018 /PRNewswire/ -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced it will report financial results for the third quarter of 2018 after market close on Thursday, November 29, 2018. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Thursday, November 29, 2018.
Oct 19, 2018 05:49 pm ET
SI-BONE Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares
SANTA CLARA, Calif., Oct. 19, 2018 /PRNewswire/ -- SI-BONE, Inc. (Nasdaq: SIBN) ("SI-BONE"), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the closing of its initial public offering of 8,280,000 shares of common stock, at a price to the public of $15.00 per share, including the full exercise by the underwriters of their option to purchase an additional 1,080,000 shares of common stock.  All of the shares of common stock were offered by SI-BONE.  The shares began trading on The Nasdaq G
Oct 16, 2018 09:18 pm ET
SI-BONE Announces Pricing of Initial Public Offering
SANTA CLARA, Calif., Oct. 16, 2018 /PRNewswire/ -- SI-BONE, Inc. (Nasdaq: SIBN) ("SI-BONE"), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the pricing of its initial public offering of 7,200,000 shares of common stock at a price to the public of $15.00 per share. In addition, SI-BONE has granted the underwriters a 30-day option to purchase up to an additional 1,080,000 shares of common stock, at the initial public offering price less underwriting discounts and commissions. The shares a

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.